← Eichor
Condition: Treatment Of Bleeding Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Treatment Of Bleeding

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Pr
Phase 4 · 2 location(s) · Sanofi · NCT06145373Nafamostat Efficacy in Phase 3 Registrational CRRT Study
NA · 10 location(s) · Talphera, Inc · NCT06150742Comparative Evaluation of SMART Hall Technique Vs. Conventional SS Crown in Primary Molars: a Randomized Clinical Trial
NA · 1 location(s) · C K S Teja Institute Of Dental Sciences & Research · NCT06453005Registry of Chronic Subdural Hematoma
Phase N/A · 2 location(s) · Erasmus Medical Center · NCT06759428A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05214391Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage
Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05664191Registry of Multimodality Treatment for Brain Arteriovenous Malformation in Mainland China
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT04572568Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura
NA · 1 location(s) · Sohag University · NCT07093606Maximal Medical Treatment of Intracerebral Haemorrhage Pilot Trial - MAX-ICH Pilot Trial
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06648369Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
Phase 1/Phase 2 · 25 location(s) · Vega Therapeutics, Inc · NCT05776069Platelet Rich Plasma for Uterine Scar
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT05224726Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Phase N/A · 18 location(s) · Zeenat Qureshi Stroke Institute · NCT06402968Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT05504941Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI
Phase 4 · 1 location(s) · University of Florida · NCT05681702Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07205861Evaluation of Dental and Periodontal Health After IPR in Patients in Orthodontic Treatment With Clear Aligners
NA · 1 location(s) · University of Campania Luigi Vanvitelli · NCT06685016Platelet Inhibitor Treated Patients With Head Injury Trauma Meeting NICE Criteria : is the CT-scan Mandatory ?
Phase N/A · 12 location(s) · Rennes University Hospital · NCT03687528Dietary Supplements to Treat Radiation-Induced Rectal Injury
Phase 2 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06776016Efficacy and Safety of Variceal Embolization Combined With Partial Splenic Artery Embolization for Variceal Bleeding in
NA · 1 location(s) · Air Force Military Medical University, China · NCT07310316Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angiop
Phase 3 · 1 location(s) · Cardiocentro Ticino · NCT07582835The Study to Evaluate the Safety and Efficacy of the Onyx Family
Phase N/A · 1 location(s) · Pusan National University Yangsan Hospital · NCT06577896Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine
NA · 4 location(s) · University Hospital, Bordeaux · NCT07195305A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
Phase N/A · 17 location(s) · Hemab ApS · NCT06610201Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed
Phase 3 · 36 location(s) · Sanofi · NCT07007962Single-dose Intravenous Iron Therapy for Anemia After Orthopaedic Trauma
Phase 4 · 1 location(s) · Oregon Health and Science University · NCT05292001An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06799611BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases
Phase 1 · 1 location(s) · iCell Gene Therapeutics · NCT06787989Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic
NA · 1 location(s) · Rajaie Cardiovascular Medical and Research Center · NCT06541691NICardipine for Fast Achievement of Systolic BP Targets in ICH
Phase 4 · 1 location(s) · Aarhus University Hospital · NCT07044232Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)
Phase 1/Phase 2 · 1 location(s) · 920th Hospital of Joint Logistics Support Force of People's · NCT06352281
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.